VSee Health, Inc. Finance Lease, Right-of-Use Asset, Amortization
VSee Health, Inc. (VSEE) reported Finance Lease, Right-of-Use Asset, Amortization of $85.98 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-14
- VSee Health, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $85.98K, a 0.00% decline year-over-year.
- VSee Health, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $85.99K, a 0.00% change year-over-year.
- VSee Health, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $85.98K, a 22.61% decline year-over-year.
- VSee Health, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $85.99K, a 0.00% change year-over-year.
- VSee Health, Inc. finance lease, right-of-use asset, amortization for fiscal 2025 was $343.94K, a 71.43% increase from fiscal 2024.
- VSee Health, Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $200.63K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $85.98K 10-Q · filed 2026-08-14 | $171.97K 10-Q · filed 2026-08-14 | $257.96K derived: sum of 3 quarters · filed 2026-08-14 | $343.94K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $85.99K 10-Q · filed 2026-05-15 | $171.97K derived: sum of 2 quarters · filed 2026-05-15 | $257.96K derived: sum of 3 quarters · filed 2026-05-15 | $343.94K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $85.98K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $171.97K derived: sum of 2 quarters · filed 2026-03-31 | $257.96K derived: sum of 3 quarters · filed 2026-08-14 | $343.94K 10-K · filed 2026-03-31 |
| 2025-09-30 | $85.99K 10-Q · filed 2025-11-14 | $171.97K derived: sum of 2 quarters · filed 2026-08-14 | $257.96K 10-Q · filed 2025-11-14 | $369.06K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $85.99K 10-Q · filed 2026-08-14 | $171.97K 10-Q · filed 2026-08-14 | $283.08K derived: sum of 3 quarters · filed 2026-08-14 | $369.06K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $85.99K 10-Q · filed 2026-05-15 | $197.09K derived: sum of 2 quarters · filed 2026-05-15 | $283.08K derived: sum of 3 quarters · filed 2026-05-15 | $286.62K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $111.11K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $197.09K derived: sum of 2 quarters · filed 2026-03-31 | $200.63K derived: sum of 3 quarters · filed 2026-03-31 | $200.63K 10-K · filed 2026-03-31 |
| 2024-09-30 | $85.99K 10-Q · filed 2025-11-14 | $89.53K derived: sum of 2 quarters · filed 2025-11-20 | $89.53K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $3.54K 10-Q/A · filed 2025-11-20 | $3.54K 10-Q/A · filed 2025-11-20 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-10-15 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-09-23 | $0.00 10-Q · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |